Redwood Grove Capital’s Amgen AMGN Stock Holding History

Redwood Grove Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-59,070	Closed	-$15.4M	–	24
2024 Q4	$15.4M	Hold	59,070	–	–	4.77%	11
2024 Q3	$19M	Buy	59,070 +8,683	+17%	+$2.84M	5.17%	6
2024 Q2	$15.7M	Buy	50,387 +2,700	+6%	+$793K	4.93%	5
2024 Q1	$13.6M	Buy	47,687 +7,000	+17%	+$2.05M	4.22%	11
2023 Q4	$11.7M	Hold	40,687	–	–	4.33%	10
2023 Q3	$10.9M	Buy	40,687 +2,000	+5%	+$499K	4.38%	9
2023 Q2	$8.59M	Sell	38,687 -5,610	-13%	-$1.3M	3.64%	16
2023 Q1	$10.7M	Hold	44,297	–	–	5.1%	8
2022 Q4	$11.6M	Hold	44,297	–	–	5.78%	5
2022 Q3	$9.98M	Hold	44,297	–	–	5.48%	6
2022 Q2	$10.8M	Hold	44,297	–	–	5.86%	7
2022 Q1	$10.8M	Hold	44,297	–	–	5.35%	8
2021 Q4	$9.96M	Buy	44,297 +15,000	+51%	+$3.17M	4.67%	11
2021 Q3	$6.23M	Buy	29,297 +8,000	+38%	+$1.84M	3.55%	13
2021 Q2	$5.19M	Hold	21,297	–	–	2.8%	18
2021 Q1	$5.3M	Hold	21,297	–	–	3.26%	15
2020 Q4	$4.9M	Buy	+21,297	New	+$4.91M	3.56%	15

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Redwood Grove Capital's AMGN Position: Q1 2025 in Review

Redwood Grove Capital sold out of Amgen (AMGN) in Q1 2025, closing a stake of 59,070 shares — an estimated $15.4M sold.

Redwood Grove Capital first reported a position in AMGN in Q4 2020 and held it in 17 quarters. The position peaked at $19M in Q3 2024. 2,930 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

Redwood Grove Capital reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
Redwood Grove Capital sold 59,070 Amgen shares in Q1 2025, an estimated $15.4M.
Redwood Grove Capital first reported a position in Amgen in Q4 2020 and held it in 17 quarters.
Redwood Grove Capital's Amgen position peaked at $19M in Q3 2024.
2,930 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Redwood Grove Capital's 13F filing for Q1 2025, filed 15 May 2025.